Status:

COMPLETED

Marin Protein Hydrolysate and Metabolic Syndrome

Lead Sponsor:

Helse Møre og Romsdal HF

Collaborating Sponsors:

Haukeland University Hospital

University of Bergen

Conditions:

Metabolic Syndrome

Eligibility:

All Genders

40-70 years

Phase:

NA

Brief Summary

Overweight and obesity are increasing global health problems and the most important contributors to morbidity and mortality. The maintenance of long-term weight loss is difficult, and individuals ofte...

Detailed Description

Overweight and obesity are increasing global health problems and the most important contributors to morbidity and mortality. Obesity (abdominal obesity), together with hyperglycemia, dyslipidemia and ...

Eligibility Criteria

Inclusion

  • Age 40-70 years
  • BMI 27-35 kg/m2
  • Signed informed consent
  • MetS as defined by the presence of at least 3 of the 5 following criteria\*:
  • Elevated waist circumference ≥ 94 cm (M), ≥ 80 cm (F)
  • Elevated triglycerides ≥ 1.7 mmol/L (150 mg/dL)
  • Elevated fasting glucose ≥ 5.5 mmol/L (100 mg/dL)
  • Elevated blood pressure S ≥ 130 and/or D ≥85 mmHg
  • Reduced HDL-cholesterol \< 1.0 mmol/L (40 mg/dL) (M) \<1.3 mmol/L (50 mg/dL) (F)
  • The International Diabetes Foundations (IDF) cut-off points are used.

Exclusion

  • Suspected allergy against fish or shellfish
  • Acute infections (may be reconsidered for inclusion at a later time)
  • Chronic disease or therapies that is likely to interfere with the evaluation study results
  • Pregnancy, lactation or planning pregnancy during study period
  • Substance misuse
  • Inability or unwillingness to comply with the requirements of study procedures

Key Trial Info

Start Date :

February 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2020

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT03807752

Start Date

February 15 2019

End Date

April 30 2020

Last Update

December 22 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Ålesund Hospital, Helse Møre og Romsdal HF

Ålesund, Norway

2

Haukeland University Hospital

Bergen, Norway